stella
beta
Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab — Stella
Recruiting
Back to Breast Cancer Triple Negative trials
Trial locations
(1 site)
United States
Emory University/Winship Cancer Institute, Atlanta, Georgia
View full record on ClinicalTrials.gov